HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abderraouf Kenani Selected Research

deglycobleomycin

9/2009Involvement of C-jun NH2-terminal kinase and apoptosis induced factor in apoptosis induced by deglycosylated bleomycin in laryngeal carcinoma cells.
7/2008Deglycosylated bleomycin triggers apoptosis in laryngeal carcinoma cells in a caspase and reactive oxygen species independent manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abderraouf Kenani Research Topics

Disease

11Neoplasms (Cancer)
01/2020 - 02/2008
6Breast Neoplasms (Breast Cancer)
08/2020 - 11/2009
5Glioblastoma (Glioblastoma Multiforme)
01/2020 - 12/2015
5Carcinoma (Carcinomatosis)
08/2010 - 02/2008
3Lymphoma (Lymphomas)
02/2016 - 07/2008
2Colorectal Neoplasms (Colorectal Cancer)
01/2020 - 12/2019
2Glioma (Gliomas)
01/2020 - 03/2016
2Triple Negative Breast Neoplasms
10/2017 - 12/2015
2Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
02/2016 - 07/2008
1Lymphatic Metastasis
10/2017
1Cardiovascular Diseases (Cardiovascular Disease)
03/2016
1Type 2 Diabetes Mellitus (MODY)
03/2016
1Obesity
03/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2016
1Overweight
03/2016
1Melanoma (Melanoma, Malignant)
02/2016
1Neoplasm Metastasis (Metastasis)
01/2016
1Ovarian Neoplasms (Ovarian Cancer)
08/2010
1Ovarian Epithelial Carcinoma
08/2010
1Cardiotoxicity
06/2010
1Laryngeal Neoplasms (Laryngeal Cancer)
09/2009
1Head and Neck Neoplasms (Head and Neck Cancer)
07/2008

Drug/Important Bio-Agent (IBA)

4Pharmaceutical PreparationsIBA
02/2016 - 09/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2010 - 04/2009
3naringinIBA
01/2020 - 01/2016
3Biomarkers (Surrogate Marker)IBA
10/2017 - 08/2010
3Cell-Penetrating PeptidesIBA
01/2016 - 11/2009
2Formaldehyde (Formol)FDA Link
01/2020 - 12/2019
2ParaffinIBA
01/2020 - 12/2019
2MicroRNAs (MicroRNA)IBA
10/2017 - 12/2015
2Matrix Metalloproteinases (MMPs)IBA
03/2016 - 01/2016
2PlatinumIBA
01/2016 - 12/2015
2maurocalcineIBA
12/2015 - 04/2009
2CaspasesIBA
09/2009 - 07/2008
2deglycobleomycinIBA
09/2009 - 07/2008
1Interleukin-6 (Interleukin 6)IBA
08/2020
1NucleotidesIBA
10/2017
1BRCA1 ProteinIBA
10/2017
1Triglycerides (Triacylglycerol)IBA
03/2016
1Peptide Hydrolases (Proteases)FDA Link
03/2016
1FlavonoidsIBA
03/2016
1Bleomycin (Blenoxane)FDA LinkGeneric
02/2016
1pyrazolanthroneIBA
01/2016
1Amino AcidsFDA Link
01/2016
1Cisplatin (Platino)FDA LinkGeneric
12/2015
16-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
12/2015
1Somatotropin Receptors (Growth Hormone Receptor)IBA
12/2015
1Keratins (Keratin)IBA
12/2015
1Phenobarbital (Luminal)FDA Link
12/2015
1AntagomirsIBA
12/2015
1Proteins (Proteins, Gene)FDA Link
08/2010
1Phosphotransferases (Kinase)IBA
09/2009
1Drug CarriersIBA
04/2009
1GlycopeptidesIBA
07/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2008
1Anti-Bacterial Agents (Antibiotics)IBA
07/2008
1Caspase 3 (Caspase-3)IBA
02/2008
1CarbohydratesIBA
02/2008
1ChromatinIBA
02/2008
1DNA (Deoxyribonucleic Acid)IBA
02/2008

Therapy/Procedure

2Therapeutics
02/2016 - 12/2015
1Combination Drug Therapy (Combination Chemotherapy)
11/2009